Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100710079> ?p ?o ?g. }
- W2100710079 endingPage "1067" @default.
- W2100710079 startingPage "1057" @default.
- W2100710079 abstract "Cyclosporin A (CsA) inhibits the P-gp pump that can be responsible for failure of cytostatic treatment in acute myeloid leukaemia (AML). Eighty patients with relapsing/refractory AML were randomly assigned to mitoxantrone (M) and etoposide (VP) (MVP) in unmitigated antileukaemic doses with or without CsA, to investigate if toxicity was manageable and if antileukaemic therapy could be improved. CsA did not delay haematological recovery, but fewer CsA patients received post-induction therapy because of haematological and non-haematological toxicity. CR rate was 43% for MVP and 53% for CsA; DFS was 9 and 8 months, and OS 8 and 9 months, respectively. Seventeen of 38 CR patients proceeded to stem cell transplantation (SCT). After a median follow-up of 66 months, six patients were still alive. Addition of CsA did not improve treatment outcome, possibly due to inadequate post-induction therapy as a result of increased toxicity." @default.
- W2100710079 created "2016-06-24" @default.
- W2100710079 creator A5000956898 @default.
- W2100710079 creator A5002972322 @default.
- W2100710079 creator A5003455280 @default.
- W2100710079 creator A5006966014 @default.
- W2100710079 creator A5010075077 @default.
- W2100710079 creator A5034779401 @default.
- W2100710079 creator A5037473051 @default.
- W2100710079 creator A5040082277 @default.
- W2100710079 creator A5043494139 @default.
- W2100710079 creator A5045018316 @default.
- W2100710079 creator A5046775582 @default.
- W2100710079 creator A5047984145 @default.
- W2100710079 creator A5070475809 @default.
- W2100710079 creator A5087823040 @default.
- W2100710079 date "2004-10-01" @default.
- W2100710079 modified "2023-10-18" @default.
- W2100710079 title "Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia:" @default.
- W2100710079 cites W1706395004 @default.
- W2100710079 cites W1949997781 @default.
- W2100710079 cites W1974257876 @default.
- W2100710079 cites W1996264890 @default.
- W2100710079 cites W2003263277 @default.
- W2100710079 cites W2005890366 @default.
- W2100710079 cites W2009814007 @default.
- W2100710079 cites W201908734 @default.
- W2100710079 cites W2028533496 @default.
- W2100710079 cites W2028966334 @default.
- W2100710079 cites W2037621239 @default.
- W2100710079 cites W2048312112 @default.
- W2100710079 cites W2063578373 @default.
- W2100710079 cites W2071492907 @default.
- W2100710079 cites W2078877172 @default.
- W2100710079 cites W2087348472 @default.
- W2100710079 cites W2125695832 @default.
- W2100710079 cites W2138993111 @default.
- W2100710079 cites W2146440927 @default.
- W2100710079 cites W2159880660 @default.
- W2100710079 cites W2168070336 @default.
- W2100710079 cites W2178680838 @default.
- W2100710079 cites W2201158929 @default.
- W2100710079 cites W2228456847 @default.
- W2100710079 cites W225277523 @default.
- W2100710079 cites W2288226674 @default.
- W2100710079 cites W2322652491 @default.
- W2100710079 cites W25713858 @default.
- W2100710079 cites W2615953705 @default.
- W2100710079 cites W3111650914 @default.
- W2100710079 cites W3113018316 @default.
- W2100710079 cites W4230518990 @default.
- W2100710079 cites W4322697658 @default.
- W2100710079 doi "https://doi.org/10.1016/j.leukres.2004.03.001" @default.
- W2100710079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15289018" @default.
- W2100710079 hasPublicationYear "2004" @default.
- W2100710079 type Work @default.
- W2100710079 sameAs 2100710079 @default.
- W2100710079 citedByCount "35" @default.
- W2100710079 countsByYear W21007100792012 @default.
- W2100710079 countsByYear W21007100792013 @default.
- W2100710079 countsByYear W21007100792014 @default.
- W2100710079 countsByYear W21007100792016 @default.
- W2100710079 countsByYear W21007100792017 @default.
- W2100710079 countsByYear W21007100792019 @default.
- W2100710079 countsByYear W21007100792020 @default.
- W2100710079 countsByYear W21007100792021 @default.
- W2100710079 crossrefType "journal-article" @default.
- W2100710079 hasAuthorship W2100710079A5000956898 @default.
- W2100710079 hasAuthorship W2100710079A5002972322 @default.
- W2100710079 hasAuthorship W2100710079A5003455280 @default.
- W2100710079 hasAuthorship W2100710079A5006966014 @default.
- W2100710079 hasAuthorship W2100710079A5010075077 @default.
- W2100710079 hasAuthorship W2100710079A5034779401 @default.
- W2100710079 hasAuthorship W2100710079A5037473051 @default.
- W2100710079 hasAuthorship W2100710079A5040082277 @default.
- W2100710079 hasAuthorship W2100710079A5043494139 @default.
- W2100710079 hasAuthorship W2100710079A5045018316 @default.
- W2100710079 hasAuthorship W2100710079A5046775582 @default.
- W2100710079 hasAuthorship W2100710079A5047984145 @default.
- W2100710079 hasAuthorship W2100710079A5070475809 @default.
- W2100710079 hasAuthorship W2100710079A5087823040 @default.
- W2100710079 hasConcept C126322002 @default.
- W2100710079 hasConcept C141071460 @default.
- W2100710079 hasConcept C142424586 @default.
- W2100710079 hasConcept C143998085 @default.
- W2100710079 hasConcept C2776694085 @default.
- W2100710079 hasConcept C2778041864 @default.
- W2100710079 hasConcept C2778119113 @default.
- W2100710079 hasConcept C2780923524 @default.
- W2100710079 hasConcept C2911091166 @default.
- W2100710079 hasConcept C29730261 @default.
- W2100710079 hasConcept C2993296363 @default.
- W2100710079 hasConcept C71924100 @default.
- W2100710079 hasConcept C86803240 @default.
- W2100710079 hasConcept C87355193 @default.
- W2100710079 hasConcept C90924648 @default.
- W2100710079 hasConcept C98274493 @default.
- W2100710079 hasConceptScore W2100710079C126322002 @default.